Ramping production of Remdesivir to meet demand: Pharma firms
The Hindu
There are seven manufacturers of Remdesivir in the country.
Several manufacturers of Remdesivir, that is being used in treatment of COVID-19, said they have ramped up production of the drug to meet its rising demand across the country. In view of increased demand for the medicine due to a spike in COVID-19 cases, the centre on Sunday prohibited the export of Remdesivir injection and its active pharmaceutical ingredients (API) till the situation in the country improves. A Zydus Cadila spokesperson said, "The current spike in COVID-19 cases has led to a higher demand of Remdesivir. We are currently producing Remdesivir at three of our facilities. To cater to the demand we have ramped up our production from the earlier 5-6 lakh vials a month to 10-12 lakh vials a month, which we will scale towards 20 lakh vials a month.” In a few weeks the supply situation will be a far more stable one, the company said.More Related News